A

Assertio Holdings

ASRT

1.37000
USD
-0.02
(-1.44%)
مغلق
حجم التداول
17,968
الربح لكل سهم
0
العائد الربحي
0
P/E
-0
حجم السوق
106,775,904
أصول ذات صلة
ABT
4.220
(3.98%)
110.150 USD
C
CAH
2.570
(2.55%)
103.390 USD
CI
-15.81
(-4.54%)
332.64 USD
CVS
-0.300
(-0.50%)
60.020 USD
GILD
0.470
(0.62%)
76.510 USD
MRK
0.680
(0.60%)
113.800 USD
PFE
0.115
(0.38%)
30.650 USD
الأخبار المقالات

العنوان: Assertio Holdings

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.